DexCom (DXCM) Competitors $64.60 -0.60 (-0.92%) As of 10:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DXCM vs. HQY, PODD, ABT, AMN, ITGR, BDX, IDXX, EW, RMD, and STEShould you be buying DexCom stock or one of its competitors? The main competitors of DexCom include HealthEquity (HQY), Insulet (PODD), Abbott Laboratories (ABT), AMN Healthcare Services (AMN), Integer (ITGR), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), ResMed (RMD), and STERIS (STE). These companies are all part of the "medical" sector. DexCom vs. Its Competitors HealthEquity Insulet Abbott Laboratories AMN Healthcare Services Integer Becton, Dickinson and Company IDEXX Laboratories Edwards Lifesciences ResMed STERIS HealthEquity (NASDAQ:HQY) and DexCom (NASDAQ:DXCM) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Is HQY or DXCM more profitable? DexCom has a net margin of 13.29% compared to HealthEquity's net margin of 11.49%. DexCom's return on equity of 30.41% beat HealthEquity's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity11.49% 12.04% 7.44% DexCom 13.29%30.41%10.08% Does the media prefer HQY or DXCM? In the previous week, DexCom had 10 more articles in the media than HealthEquity. MarketBeat recorded 23 mentions for DexCom and 13 mentions for HealthEquity. DexCom's average media sentiment score of 0.84 beat HealthEquity's score of 0.68 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 10 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, HQY or DXCM? DexCom has higher revenue and earnings than HealthEquity. DexCom is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$1.20B6.74$96.70M$1.6556.90DexCom$4.03B6.28$576.20M$1.4444.86 Do analysts rate HQY or DXCM? HealthEquity currently has a consensus price target of $121.31, indicating a potential upside of 29.21%. DexCom has a consensus price target of $97.42, indicating a potential upside of 50.81%. Given DexCom's higher probable upside, analysts plainly believe DexCom is more favorable than HealthEquity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.93DexCom 0 Sell rating(s) 6 Hold rating(s) 14 Buy rating(s) 3 Strong Buy rating(s) 2.87 Which has more risk & volatility, HQY or DXCM? HealthEquity has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Do institutionals and insiders have more ownership in HQY or DXCM? 99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryDexCom beats HealthEquity on 11 of the 17 factors compared between the two stocks. Get DexCom News Delivered to You Automatically Sign up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DXCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXCM vs. The Competition Export to ExcelMetricDexComMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.46B$6.84B$6.02B$10.34BDividend YieldN/A1.19%5.73%4.82%P/E Ratio45.0826.6184.7826.75Price / Sales6.2827.48598.92130.97Price / Cash28.9721.8525.7730.18Price / Book12.015.1312.476.64Net Income$576.20M$178.09M$3.32B$276.55M7 Day Performance-2.17%-2.56%-0.56%-0.93%1 Month Performance-15.25%6.60%8.20%6.04%1 Year Performance-6.62%3.31%75.60%40.02% DexCom Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXCMDexCom4.9301 of 5 stars$64.60-0.9%$97.42+50.8%-5.8%$25.46B$4.03B45.0810,300HQYHealthEquity4.2185 of 5 stars$87.78-0.9%$119.77+36.4%+9.1%$7.56B$1.20B53.203,120Positive NewsPODDInsulet4.7078 of 5 stars$311.69+0.8%$346.83+11.3%+34.9%$21.94B$2.07B94.743,900ABTAbbott Laboratories4.9593 of 5 stars$133.63-0.7%$145.39+8.8%+13.3%$232.58B$43.11B16.75114,000Positive NewsUpcoming EarningsAnalyst ForecastAMNAMN Healthcare Services4.2945 of 5 stars$19.83-3.4%$23.25+17.2%-51.7%$759.97M$2.77B-2.552,968News CoverageAnalyst ForecastGap UpITGRInteger3.7433 of 5 stars$105.33+0.3%$139.57+32.5%-20.9%$3.69B$1.72B46.4011,000Positive NewsBDXBecton, Dickinson and Company4.944 of 5 stars$191.94-0.9%$205.40+7.0%-21.0%$55.02B$21.39B34.5274,000Positive NewsIDXXIDEXX Laboratories4.3487 of 5 stars$627.78-0.5%$656.50+4.6%+33.0%$50.23B$4.04B52.2711,000Positive NewsAnalyst RevisionEWEdwards Lifesciences4.8932 of 5 stars$76.59-0.6%$86.61+13.1%+7.1%$44.97B$5.44B11.0215,800Positive NewsRMDResMed4.5644 of 5 stars$281.76+1.1%$294.20+4.4%+13.6%$41.25B$5.15B29.6310,600Positive NewsAnalyst ForecastSTESTERIS4.8822 of 5 stars$240.58-0.8%$273.50+13.7%+3.9%$23.69B$5.57B36.8417,787Positive News Related Companies and Tools Related Companies HealthEquity Competitors Insulet Competitors Abbott Laboratories Competitors AMN Healthcare Services Competitors Integer Competitors Becton, Dickinson and Company Competitors IDEXX Laboratories Competitors Edwards Lifesciences Competitors ResMed Competitors STERIS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DXCM) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
